 | • レポートコード：QYR9NV16547 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のナチュラルキラー細胞療法市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。ナチュラルキラー細胞療法の種類別には、NK細胞療法、NK細胞向け抗体に、用途別には、がん、消化器疾患、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・ナチュラルキラー細胞療法の種類別市場規模：NK細胞療法、NK細胞向け抗体 ・ナチュラルキラー細胞療法の用途別市場規模：がん、消化器疾患、その他 ・ナチュラルキラー細胞療法の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Nektar Therapeutics、Innate、Affimed、Chipscreen Biosciences、Fate Therapeutics、Glycostem、Dragonfly Therapeutics、Kiadis Pharma、NantWorks、Nkarta Therapeutics、Fortress Biotech ・市場規模予測2019-2025：生産量 ・市場規模予測2019-2025：消費量 ・バリューチェーン・販売チャネル分析 ・市場機会・課題分析 ... |
Cell therapy, a new therapeutic approach that uses a patient’s own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment.In 2018, the global Natural Killer Cell Therapies market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Natural Killer Cell Therapies.
This study researches the market size of Natural Killer Cell Therapies, presents the global Natural Killer Cell Therapies sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Natural Killer Cell Therapies in key regions like North America, Europe, China and Japan, presents sales, revenue, market share, growth rate of Natural Killer Cell Therapies for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.
This report includes the following manufacturers; we can also add the other companies as you want.
Innate
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech
Market Segment by Product Type
NK Cell Therapies
NK Cell Directed Antibodies
Market Segment by Application
Cancer
Gastrointestinal Diseases
Others
Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives are:
To analyze and research the global Natural Killer Cell Therapies status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Natural Killer Cell Therapies manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Natural Killer Cell Therapies are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Natural Killer Cell Therapies Market Size Growth Rate by Type
1.3.2 NK Cell Therapies
1.3.3 NK Cell Directed Antibodies
1.4 Market Segment by Application
1.4.1 Global Natural Killer Cell Therapies Market Share by Application (2019-2025)
1.4.2 Cancer
1.4.3 Gastrointestinal Diseases
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Natural Killer Cell Therapies Market Size
2.1.1 Global Natural Killer Cell Therapies Revenue 2014-2025
2.1.2 Global Natural Killer Cell Therapies Sales 2014-2025
2.2 Natural Killer Cell Therapies Growth Rate by Regions
2.2.1 Global Natural Killer Cell Therapies Sales by Regions 2014-2019
2.2.2 Global Natural Killer Cell Therapies Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Natural Killer Cell Therapies Sales by Manufacturers
3.1.1 Natural Killer Cell Therapies Sales by Manufacturers 2014-2019
3.1.2 Natural Killer Cell Therapies Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Natural Killer Cell Therapies Revenue by Manufacturers (2014-2019)
3.2.2 Natural Killer Cell Therapies Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Natural Killer Cell Therapies Market Concentration Ratio (CR5 and HHI)
3.3 Natural Killer Cell Therapies Price by Manufacturers
3.4 Key Manufacturers Natural Killer Cell Therapies Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Natural Killer Cell Therapies Market
3.6 Key Manufacturers Natural Killer Cell Therapies Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 NK Cell Therapies Sales and Revenue (2014-2019)
4.1.2 NK Cell Directed Antibodies Sales and Revenue (2014-2019)
4.2 Global Natural Killer Cell Therapies Sales Market Share by Type
4.3 Global Natural Killer Cell Therapies Revenue Market Share by Type
4.4 Natural Killer Cell Therapies Price by Type
5 Market Size by Application
5.1 Overview
5.1 Global Natural Killer Cell Therapies Sales by Application
6 North America
6.1 North America Natural Killer Cell Therapies Breakdown Data by Company
6.2 North America Natural Killer Cell Therapies Breakdown Data by Type
6.3 North America Natural Killer Cell Therapies Breakdown Data by Application
6.4 North America Natural Killer Cell Therapies Breakdown Data by Countries
6.4.1 North America Natural Killer Cell Therapies Sales by Countries
6.4.2 North America Natural Killer Cell Therapies Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
7 Europe
7.1 Europe Natural Killer Cell Therapies Breakdown Data by Company
7.2 Europe Natural Killer Cell Therapies Breakdown Data by Type
7.3 Europe Natural Killer Cell Therapies Breakdown Data by Application
7.4 Europe Natural Killer Cell Therapies Breakdown Data by Countries
7.4.1 Europe Natural Killer Cell Therapies Sales by Countries
7.4.2 Europe Natural Killer Cell Therapies Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Natural Killer Cell Therapies Breakdown Data by Company
8.2 Asia Pacific Natural Killer Cell Therapies Breakdown Data by Type
8.3 Asia Pacific Natural Killer Cell Therapies Breakdown Data by Application
8.4 Asia Pacific Natural Killer Cell Therapies Breakdown Data by Regions
8.4.1 Asia Pacific Natural Killer Cell Therapies Sales by Countries
8.4.2 Asia Pacific Natural Killer Cell Therapies Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
9 Central & South America
9.1 Central & South America Natural Killer Cell Therapies Breakdown Data by Company
9.2 Central & South America Natural Killer Cell Therapies Breakdown Data by Type
9.3 Central & South America Natural Killer Cell Therapies Breakdown Data by Application
9.4 Central & South America Natural Killer Cell Therapies Breakdown Data by Countries
9.4.1 Central & South America Natural Killer Cell Therapies Sales by Countries
9.4.2 Central & South America Natural Killer Cell Therapies Revenue by Countries
9.4.3 Brazil
10 Middle East and Africa
10.1 Middle East and Africa Natural Killer Cell Therapies Breakdown Data by Type
10.2 Middle East and Africa Natural Killer Cell Therapies Breakdown Data by Application
10.3 Middle East and Africa Natural Killer Cell Therapies Breakdown Data by Countries
10.3.1 Middle East and Africa Natural Killer Cell Therapies Sales by Countries
10.3.2 Middle East and Africa Natural Killer Cell Therapies Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa
11 Company Profiles
11.1 Nektar Therapeutics
11.1.1 Nektar Therapeutics Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Natural Killer Cell Therapies
11.1.4 Natural Killer Cell Therapies Product Introduction
11.1.5 Nektar Therapeutics Recent Development
11.2 Innate
11.2.1 Innate Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Natural Killer Cell Therapies
11.2.4 Natural Killer Cell Therapies Product Introduction
11.2.5 Innate Recent Development
11.3 Affimed
11.3.1 Affimed Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Natural Killer Cell Therapies
11.3.4 Natural Killer Cell Therapies Product Introduction
11.3.5 Affimed Recent Development
11.4 Chipscreen Biosciences
11.4.1 Chipscreen Biosciences Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Natural Killer Cell Therapies
11.4.4 Natural Killer Cell Therapies Product Introduction
11.4.5 Chipscreen Biosciences Recent Development
11.5 Fate Therapeutics
11.5.1 Fate Therapeutics Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Natural Killer Cell Therapies
11.5.4 Natural Killer Cell Therapies Product Introduction
11.5.5 Fate Therapeutics Recent Development
11.6 Glycostem
11.6.1 Glycostem Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Natural Killer Cell Therapies
11.6.4 Natural Killer Cell Therapies Product Introduction
11.6.5 Glycostem Recent Development
11.7 Dragonfly Therapeutics
11.7.1 Dragonfly Therapeutics Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Natural Killer Cell Therapies
11.7.4 Natural Killer Cell Therapies Product Introduction
11.7.5 Dragonfly Therapeutics Recent Development
11.8 Kiadis Pharma
11.8.1 Kiadis Pharma Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Natural Killer Cell Therapies
11.8.4 Natural Killer Cell Therapies Product Introduction
11.8.5 Kiadis Pharma Recent Development
11.9 NantWorks
11.9.1 NantWorks Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Natural Killer Cell Therapies
11.9.4 Natural Killer Cell Therapies Product Introduction
11.9.5 NantWorks Recent Development
11.10 Nkarta Therapeutics
11.10.1 Nkarta Therapeutics Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Natural Killer Cell Therapies
11.10.4 Natural Killer Cell Therapies Product Introduction
11.10.5 Nkarta Therapeutics Recent Development
11.11 Fortress Biotech
12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Natural Killer Cell Therapies Sales Channels
12.2.2 Natural Killer Cell Therapies Distributors
12.3 Natural Killer Cell Therapies Customers
13 Market Forecast
13.1 Global Natural Killer Cell Therapies Sales and Revenue Forecast 2019-2025
13.2 Global Natural Killer Cell Therapies Sales Forecast by Type
13.3 Global Natural Killer Cell Therapies Sales Forecast by Application
13.4 Natural Killer Cell Therapies Forecast by Regions
13.4.1 Global Natural Killer Cell Therapies Sales Forecast by Regions 2019-2025
13.4.2 Global Natural Killer Cell Therapies Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Natural Killer Cell Therapies Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Natural Killer Cell Therapies Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Natural Killer Cell Therapies Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.8 Central & South America Market Forecast
13.8.1 Central & South America Natural Killer Cell Therapies Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Natural Killer Cell Therapies Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Figure Natural Killer Cell Therapies Product Picture
Table Natural Killer Cell Therapies Key Market Segments
Table Major Manufacturers Natural Killer Cell Therapies Covered in This Report
Table Global Natural Killer Cell Therapies Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Natural Killer Cell Therapies Sales Market Shar by Type 2014-2025
Figure NK Cell Therapies Figures
Table Major Manufacturers of NK Cell Therapies
Figure NK Cell Directed Antibodies Figures
Table Major Manufacturers of NK Cell Directed Antibodies
Table Global Natural Killer Cell Therapies Market Share by Application 2019-2025 (K Units)
Figure Cancer Use Case
Figure Gastrointestinal Diseases Use Case
Figure Others Use Case
Figure Natural Killer Cell Therapies Report Years Considered
Figure Global Natural Killer Cell Therapies Market Size 2014-2025 (Million US$)
Figure Global Natural Killer Cell Therapies Sales 2014-2019 (K Units)
Table Global Natural Killer Cell Therapies Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Natural Killer Cell Therapies Sales by Regions 2014-2019 (K Units)
Table Global Natural Killer Cell Therapies Sales Market Share by Regions 2014-2019
Figure Global Natural Killer Cell Therapies Sales Market Share by Regions 2014-2019
Figure Global Natural Killer Cell Therapies Sales Market Share by Regions in 2018
Table Global Natural Killer Cell Therapies Revenue by Regions 2014-2019 (Million US$)
Table Global Natural Killer Cell Therapies Revenue Market Share by Regions 2014-2019
Figure Global Natural Killer Cell Therapies Revenue Market Share by Regions 2014-2019
Figure Global Natural Killer Cell Therapies Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Natural Killer Cell Therapies Sales by Manufacturers (2014-2019) (K Units)
Table Global Natural Killer Cell Therapies Sales Share by Manufacturers (2014-2019)
Figure Global Natural Killer Cell Therapies Sales Share by Manufacturers in 2018
Table Natural Killer Cell Therapies Revenue by Manufacturers (2014-2019) (Million USD)
Table Natural Killer Cell Therapies Revenue Share by Manufacturers (2014-2019)
Figure Natural Killer Cell Therapies Value Share by Manufacturers in 2018
Table Global Natural Killer Cell Therapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Natural Killer Cell Therapies Price (2014-2019) (USD/Unit)
Table Key Manufacturers Natural Killer Cell Therapies Plants/Factories Distribution
Table Key Manufacturers Natural Killer Cell Therapies Area Served
Table Date of Key Manufacturers Enter into Natural Killer Cell Therapies Market
Table Key Manufacturers Natural Killer Cell Therapies Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global NK Cell Therapies Sales an目录输出!D Revenue (2014-2019) (K Units) & (Million US$)
Table Global NK Cell Directed Antibodies Sales an目录输出!D Revenue (2014-2019) (K Units) & (Million US$)
Table Global Natural Killer Cell Therapies Sales by Type (2014-2019) (K Units)
Table Global Natural Killer Cell Therapies Sales Share by Type (2014-2019)
Figure Global Natural Killer Cell Therapies Sales Market Share by Type (2014-2019)
Figure Global Natural Killer Cell Therapies Sales Market Share by Type in 2018
Table Global Natural Killer Cell Therapies Revenue by Type (2014-2019) (Million US$)
Table Global Natural Killer Cell Therapies Revenue Share by Type (2014-2019)
Figure Global Natural Killer Cell Therapies Revenue Market Share by Type (2014-2019)
Figure Global Natural Killer Cell Therapies Revenue Market Share by Type in 2018
Table Natural Killer Cell Therapies Price by Type 2014-2019 (USD/Unit)
Table Global Natural Killer Cell Therapies Sales by Application (2014-2019) (K Units)
Table Global Natural Killer Cell Therapies Sales Share by Application (2014-2019)
Figure Global Sales Natural Killer Cell Therapies Market Share by Application (2014-2019)
Figure Global Sales Natural Killer Cell Therapies Market Share by Application in 2018
Figure North America Natural Killer Cell Therapies Sales Growth Rate 2014-2019 (K Units)
Figure North America Natural Killer Cell Therapies Revenue Growth Rate 2014-2019 (Million US$)
Table North America Natural Killer Cell Therapies Sales by Company (2014-2019) (K Units)
Table North America Natural Killer Cell Therapies Sales Market Share by Company (2014-2019)
Figure North America Natural Killer Cell Therapies Sales Market Share by Company in 2018
Table North America Natural Killer Cell Therapies Sales by Type (2014-2019) (K Units)
Table North America Natural Killer Cell Therapies Sales Market Share by Type (2014-2019)
Figure North America Natural Killer Cell Therapies Market Share by Type in 2018
Table North America Natural Killer Cell Therapies Sales by Application (2014-2019) (K Units)
Table North America Natural Killer Cell Therapies Sales Market Share by Application (2014-2019)
Figure North America Natural Killer Cell Therapies Market Share by Application in 2018
Table North America Natural Killer Cell Therapies Sales by Countries (2014-2019) (K Units)
Table North America Natural Killer Cell Therapies Sales Market Share by Countries (2014-2019)
Figure North America Natural Killer Cell Therapies Sales Market Share by Countries in 2018
Table North America Natural Killer Cell Therapies Revenue by Countries (2014-2019) (Million US$)
Table North America Natural Killer Cell Therapies Revenue Market Share by Countries (2014-2019)
Figure North America Natural Killer Cell Therapies Revenue Market Share by Countries in 2018
Figure United States Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Canada Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Europe Natural Killer Cell Therapies Sales Growth Rate 2014-2019 (K Units)
Figure Europe Natural Killer Cell Therapies Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Natural Killer Cell Therapies Sales by Company (2014-2019) (K Units)
Table Europe Natural Killer Cell Therapies Sales Market Share by Company (2014-2019)
Figure Europe Natural Killer Cell Therapies Sales Market Share by Company in 2018
Table Europe Natural Killer Cell Therapies Sales by Type (2014-2019) (K Units)
Table Europe Natural Killer Cell Therapies Sales Market Share by Type (2014-2019)
Figure Europe Natural Killer Cell Therapies Sales Market Share by Type in 2018
Table Europe Natural Killer Cell Therapies Sales by Application (2014-2019) (K Units)
Table Europe Natural Killer Cell Therapies Sales Market Share by Application (2014-2019)
Figure Europe Natural Killer Cell Therapies Sales Market Share by Application in 2018
Table Europe Natural Killer Cell Therapies Sales by Countries (2014-2019) (K Units)
Table Europe Natural Killer Cell Therapies Sales Market Share by Countries (2014-2019)
Figure Europe Natural Killer Cell Therapies Sales Market Share by Countries in 2018
Table Europe Natural Killer Cell Therapies Revenue by Countries (2014-2019) (Million US$)
Table Europe Natural Killer Cell Therapies Revenue Market Share by Countries (2014-2019)
Figure Europe Natural Killer Cell Therapies Revenue Market Share by Countries in 2018
Figure Germany Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure France Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure UK Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Italy Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Russia Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Asia Pacific Natural Killer Cell Therapies Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Natural Killer Cell Therapies Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Natural Killer Cell Therapies Sales by Regions (2014-2019) (K Units)
Table Asia Pacific Natural Killer Cell Therapies Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Natural Killer Cell Therapies Sales Market Share by Regions in 2018
Table Asia Pacific Natural Killer Cell Therapies Sales by Type (2014-2019) (K Units)
Table Asia Pacific Natural Killer Cell Therapies Sales Market Share by Type (2014-2019)
Figure Asia Pacific Natural Killer Cell Therapies Market Share by Type in 2018
Table Asia Pacific Natural Killer Cell Therapies Sales by Application (2014-2019) (K Units)
Table Asia Pacific Natural Killer Cell Therapies Sales Market Share by Application (2014-2019)
Figure Asia Pacific Natural Killer Cell Therapies Market Share by Application in 2018
Table Asia Pacific Natural Killer Cell Therapies Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Natural Killer Cell Therapies Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Natural Killer Cell Therapies Sales Market Share by Regions in 2018
Table Asia Pacific Natural Killer Cell Therapies Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific Natural Killer Cell Therapies Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific Natural Killer Cell Therapies Revenue Market Share by Regions in 2018
Figure China Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure China Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Japan Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Korea Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Figure India Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure India Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Australia Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America Natural Killer Cell Therapies Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Natural Killer Cell Therapies Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Natural Killer Cell Therapies Sales by Company (2014-2019) (K Units)
Table Central & South America Natural Killer Cell Therapies Sales Market Share by Company (2014-2019)
Figure Central & South America Natural Killer Cell Therapies Sales Market Share by Company in 2018
Table Central & South America Natural Killer Cell Therapies Sales by Type (2014-2019) (K Units)
Table Central & South America Natural Killer Cell Therapies Sales Market Share by Type (2014-2019)
Figure Central & South America Natural Killer Cell Therapies Market Share by Type in 2018
Table Central & South America Natural Killer Cell Therapies Sales by Application (2014-2019) (K Units)
Table Central & South America Natural Killer Cell Therapies Sales Market Share by Application (2014-2019)
Figure Central & South America Natural Killer Cell Therapies Market Share by Application in 2018
Table Central & South America Natural Killer Cell Therapies Sales by Countries (2014-2019) (K Units)
Table Central & South America Natural Killer Cell Therapies Sales Market Share by Countries (2014-2019)
Figure Central & South America Natural Killer Cell Therapies Sales Market Share by Countries in 2018
Table Central & South America Natural Killer Cell Therapies Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Natural Killer Cell Therapies Revenue Market Share by Countries (2014-2019)
Figure Central & South America Natural Killer Cell Therapies Revenue Market Share by Countries in 2018
Figure Brazil Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (K Units)
Figure Middle East and Africa Natural Killer Cell Therapies Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Natural Killer Cell Therapies Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Natural Killer Cell Therapies Sales by Type (2014-2019) (K Units)
Table Middle East and Africa Natural Killer Cell Therapies Sales Market Share by Type (2014-2019)
Figure Middle East and Africa Natural Killer Cell Therapies Sales Market Share by Type in 2018
Table Middle East and Africa Natural Killer Cell Therapies Sales by Application (2014-2019) (K Units)
Table Middle East and Africa Natural Killer Cell Therapies Sales Market Share by Application (2014-2019)
Figure Middle East and Africa Natural Killer Cell Therapies Sales Market Share by Application in 2018
Table Middle East and Africa Natural Killer Cell Therapies Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Natural Killer Cell Therapies Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Natural Killer Cell Therapies Sales Market Share by Countries in 2018
Table Middle East and Africa Natural Killer Cell Therapies Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Natural Killer Cell Therapies Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Natural Killer Cell Therapies Revenue Market Share by Countries in 2018
Figure GCC Countries Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (K Units)
Figure Egypt Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (K Units)
Figure South Africa Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (K Units)
Table Nektar Therapeutics Company Details
Table Nektar Therapeutics Description and Business Overview
Table Nektar Therapeutics Natural Killer Cell Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Nektar Therapeutics Natural Killer Cell Therapies Sales Growth Rate (2014-2019)
Table Nektar Therapeutics Natural Killer Cell Therapies Sales Market Share in Global Market
Table Nektar Therapeutics Recent Development
Table Innate Company Details
Table Innate Description and Business Overview
Table Innate Natural Killer Cell Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Innate Natural Killer Cell Therapies Sales Growth Rate (2014-2019)
Table Innate Natural Killer Cell Therapies Sales Market Share in Global Market
Table Innate Recent Development
Table Affimed Company Details
Table Affimed Description and Business Overview
Table Affimed Natural Killer Cell Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Affimed Natural Killer Cell Therapies Sales Growth Rate (2014-2019)
Table Affimed Natural Killer Cell Therapies Sales Market Share in Global Market
Table Affimed Recent Development
Table Chipscreen Biosciences Company Details
Table Chipscreen Biosciences Description and Business Overview
Table Chipscreen Biosciences Natural Killer Cell Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Chipscreen Biosciences Natural Killer Cell Therapies Sales Growth Rate (2014-2019)
Table Chipscreen Biosciences Natural Killer Cell Therapies Sales Market Share in Global Market
Table Chipscreen Biosciences Recent Development
Table Fate Therapeutics Company Details
Table Fate Therapeutics Description and Business Overview
Table Fate Therapeutics Natural Killer Cell Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Fate Therapeutics Natural Killer Cell Therapies Sales Growth Rate (2014-2019)
Table Fate Therapeutics Natural Killer Cell Therapies Sales Market Share in Global Market
Table Fate Therapeutics Recent Development
Table Glycostem Company Details
Table Glycostem Description and Business Overview
Table Glycostem Natural Killer Cell Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Glycostem Natural Killer Cell Therapies Sales Growth Rate (2014-2019)
Table Glycostem Natural Killer Cell Therapies Sales Market Share in Global Market
Table Glycostem Recent Development
Table Dragonfly Therapeutics Company Details
Table Dragonfly Therapeutics Description and Business Overview
Table Dragonfly Therapeutics Natural Killer Cell Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Dragonfly Therapeutics Natural Killer Cell Therapies Sales Growth Rate (2014-2019)
Table Dragonfly Therapeutics Natural Killer Cell Therapies Sales Market Share in Global Market
Table Dragonfly Therapeutics Recent Development
Table Kiadis Pharma Company Details
Table Kiadis Pharma Description and Business Overview
Table Kiadis Pharma Natural Killer Cell Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Kiadis Pharma Natural Killer Cell Therapies Sales Growth Rate (2014-2019)
Table Kiadis Pharma Natural Killer Cell Therapies Sales Market Share in Global Market
Table Kiadis Pharma Recent Development
Table NantWorks Company Details
Table NantWorks Description and Business Overview
Table NantWorks Natural Killer Cell Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table NantWorks Natural Killer Cell Therapies Sales Growth Rate (2014-2019)
Table NantWorks Natural Killer Cell Therapies Sales Market Share in Global Market
Table NantWorks Recent Development
Table Nkarta Therapeutics Company Details
Table Nkarta Therapeutics Description and Business Overview
Table Nkarta Therapeutics Natural Killer Cell Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Nkarta Therapeutics Natural Killer Cell Therapies Sales Growth Rate (2014-2019)
Table Nkarta Therapeutics Natural Killer Cell Therapies Sales Market Share in Global Market
Table Nkarta Therapeutics Recent Development
Table Fortress Biotech Company Details
Figure Natural Killer Cell Therapies Value Chain
Table Natural Killer Cell Therapies Distributors List
Table Natural Killer Cell Therapies Customers List
Table Global Natural Killer Cell Therapies Sales Forecast 2019-2025 (K Units) & (Million US$)
Figure Global Natural Killer Cell Therapies Sales Forecast 2019-2025 (K Units)
Figure Global Natural Killer Cell Therapies Revenue Forecast 2019-2025 (Million US$)
Table Global Natural Killer Cell Therapies Sales Forecast by Type 2019-2025 (K Units)
Figure Global Natural Killer Cell Therapies Sales Forecast by Type 2019-2025 (K Units)
Figure Global Natural Killer Cell Therapies Sales Market Share Forecast by Type 2019-2025
Table Global Natural Killer Cell Therapies Sales Forecast by Application 2019-2025 (K Units)
Figure Global Natural Killer Cell Therapies Sales Forecast by Application 2019-2025 (K Units)
Figure Global Natural Killer Cell Therapies Sales Market Share Forecast by Application 2019-2025
Table Global Natural Killer Cell Therapies Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Natural Killer Cell Therapies Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Natural Killer Cell Therapies Sales Market Share Forecast by Regions 2019-2025
Table Global Natural Killer Cell Therapies Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Natural Killer Cell Therapies Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Natural Killer Cell Therapies Revenue Market Share Forecast by Regions 2019-2025
Table North America Natural Killer Cell Therapies Sales Forecast by Countries 2019-2025 (K Units)
Table North America Natural Killer Cell Therapies Sales Market Share Forecast by Countries 2019-2025
Table North America Natural Killer Cell Therapies Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America Natural Killer Cell Therapies Revenue Market Share Forecast by Countries 2019-2025
Figure United States Natural Killer Cell Therapies Sales Forecast 2019-2025 (K Units)
Figure Canada Natural Killer Cell Therapies Sales Forecast 2019-2025 (K Units)
Figure Mexico Natural Killer Cell Therapies Sales Forecast 2019-2025 (K Units)
Table Europe Natural Killer Cell Therapies Sales Forecast by Countries 2019-2025 (K Units)
Table Europe Natural Killer Cell Therapies Sales Market Share Forecast by Countries 2019-2025
Table Europe Natural Killer Cell Therapies Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe Natural Killer Cell Therapies Revenue Market Share Forecast by Countries 2019-2025
Figure Germany Natural Killer Cell Therapies Sales Forecast 2019-2025 (K Units)
Figure France Natural Killer Cell Therapies Sales Forecast 2019-2025 (K Units)
Figure UK Natural Killer Cell Therapies Sales Forecast 2019-2025 (K Units)
Figure Italy Natural Killer Cell Therapies Sales Forecast 2019-2025 (K Units)
Figure Russia Natural Killer Cell Therapies Sales Forecast 2019-2025 (K Units)
Table Asia Pacific Natural Killer Cell Therapies Sales Forecast by Regions 2019-2025 (K Units)
Table Asia Pacific Natural Killer Cell Therapies Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific Natural Killer Cell Therapies Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific Natural Killer Cell Therapies Revenue Market Share Forecast by Regions 2019-2025
Figure China Natural Killer Cell Therapies Sales Forecast 2019-2025 (K Units)
Figure Japan Natural Killer Cell Therapies Sales Forecast 2019-2025 (K Units)
Figure South Korea Natural Killer Cell Therapies Sales Forecast 2019-2025 (K Units)
Figure India Natural Killer Cell Therapies Sales Forecast 2019-2025 (K Units)
Table Central & South America Natural Killer Cell Therapies Sales Forecast by Countries 2019-2025 (K Units)
Table Central & South America Natural Killer Cell Therapies Sales Market Share Forecast by Countries 2019-2025
Table Central & South America Natural Killer Cell Therapies Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America Natural Killer Cell Therapies Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil Natural Killer Cell Therapies Sales Forecast 2019-2025 (K Units)
Table Middle East and Africa Natural Killer Cell Therapies Sales Forecast by Regions 2019-2025 (K Units)
Table Middle East and Africa Natural Killer Cell Therapies Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa Natural Killer Cell Therapies Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa Natural Killer Cell Therapies Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey Natural Killer Cell Therapies Sales Forecast 2019-2025 (K Units)
Figure GCC Countries Natural Killer Cell Therapies Sales Forecast 2019-2025 (K Units)
Figure Egypt Natural Killer Cell Therapies Sales Forecast 2019-2025 (K Units)
Figure South Africa Natural Killer Cell Therapies Sales Forecast 2019-2025 (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のナチュラルキラー細胞療法産業調査2019-2025 Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment.In 2018, the global Natural Killer Cell Therapies market size was xx million US$ and is forecast to xx million US in 2025, grow…- ナチュラルキラー細胞治療薬のグローバル市場：規模・現状・予測2019-2025 Cell therapy, a new therapeutic approach that uses a patient’s own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body’s first line of defense against infections and diseases with an innate ability to rapidly seek and destr…
- ナチュラルキラー細胞治療薬のグローバル市場：規模・現状・予測2019-2025 Cell therapy, a new therapeutic approach that uses a patient’s own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body’s first line of defense against infections and diseases with an innate ability to rapidly seek and destr…
- B細胞成熟抗原（BCMA）標的療法のグローバル市場調査 2019年 The global B-Cell Maturation Antigen(BCMA) Targeted Therapies market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on B-Cell Maturation Antigen(BCMA) Targeted Therapies volume and value at global level, reg…
- 卵巣がんの治療および診断のグローバル市場：規模・現状・予測2019-2025 Ovarian cancer (ovarian cancer) accounts for 2.4% ~ 6.5% of the common malignant tumors in women, and ranks the third among the cancers of the female reproductive system, secondary to cervical cancer and uterine body cancer.In recent years, due to the prevention and treatment of cervical cancer and …